A novel simple, direct and selective gas chromatography-mass spectrometry (GC/MS) procedure was developed for the determination of the antihistamine drug dimenhydrinate (DMH) in presence of six of its related substances and potential impurities, namely, diphenylmethane, diphenylmethanol, benzophenone, orphenadrine, caffeine and 8-chlorocaffeine. The method involved resolution of the underivatized compounds using a trifluoropropylmethyl polysiloxane (Rtx-200) capillary column and the mass spectrometric detection was carried out in the electronimpact (EI) mode. Excellent baseline separation of DMH and the cited related substances was achieved in less than 15 min. Quantification of the parent drug DMH was based on measuring its peak area. The reliability and analytical performance of the proposed method were validated with respect to linearity, range, precision, accuracy, specificity, robustness, detection and quantification limits. Calibration curve of DMH was linear over the range 50-500 lg/mL with determination coefficient (R 2 ) = 0.9982. The proposed method was successfully applied for the assay of DMH in tablets dosage form with recoveries >96.80%.
Introduction
Dimenhydrinate (DMH) is the diphenhydramine salt of 8-chlorotheophylline. It is chemically known as a (1:1) compound of 8-chloro-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione with 2-(diphenylmethoxy)-N,N-dimethylethanamine [1] . DMH is an antihistamine with antimuscarinic and significant sedative effects [2] . It is mainly used as an antiemetic in the prevention and treatment of motion sickness [2] . It is also used for the symptomatic treatment of nausea and vertigo caused by Me´nie`re's disease and other vestibular disturbances [2] . The quantification of DMH in various drug formulations and/or biological samples was addressed in several reports. Analytical methodology in these reports involved the use of spectrophotometry [3, 4] , adsorptive stripping voltammetry [5] , capillary electrophoresis [6] , liquid chromatography-tandem mass spectrometry (LC/MS/MS) [7] , high performance liquid chromatography (HPLC) with fluorescence detection [8] , HPLC with UV detection [9] and high performance thin layer chromatography (HPTLC) [10, 11] . Recently, an electrochemical method based on batch injection analysis with multiple pulsed amperometric detection was reported for stoichiometric determination of DMH [12] .
Few GC/MS methods could be found in the scientific literature for the analysis of DMH merely for toxicological and forensic purposes [13, 14] . Furthermore, few articles described the application of gas chromatography (GC) in analysis of diphenhydramine which is one of the two components of DMH. The simultaneous determination of diphenhydramine and pseudoephedrine in cough syrup was carried out using GC with flame ionization detector (FID) [15] . On the other hand, GC coupled with either nitrogen-phosphorus detection (NPD) or mass selective detection (MSD) was exploited for the determination of diphenhydramine in several biological samples [16, 17] . Finally, GC/MS was applied for the identification of diphenhydramine and its metabolites along with other drugs commonly detected in clinical toxicology laboratories [18] .
Although not widely used in pharmaceutical analysis, GC/MS can be considered one of the powerful techniques for separation and analysis of complex mixtures. We previously published the selective determination of some pharmaceutical compounds in presence of their related substances using direct GC/MS methods [19, 20] . Reviewing the literature revealed the use of gradient elution RP-HPLC with UV detection methods for the separation of DMH together with its related substances and impurities [21, 22] . DMH related substances which are involved in this study are diphenylmethane, diphenylmethanol (benzhydrol), benzophenone, orphenadrine, caffeine and 8-chlorocaffeine [21] [22] [23] . Chemical structures of the parent drug and the related substances are shown in Fig. 1 . To the best of our knowledge, there were no reports for the application of GC/MS in the analysis of DMH in pharmaceutical preparations. Additionally, there were no GC reports for the selective determination of DMH in presence of its related substances, degradation products or impurities. This work describes a simple, direct and selective capillary GC/MS method for the separation of DMH together with the above-mentioned related substances. The described method proved to be suitable for the quality assessment of DMH in its tablets. General procedure and construction of calibration graph DMH and its related substances are all readily soluble in acetonitrile. DMH (1000 lg/mL) stock solution was prepared in acetonitrile. DMH working solutions were prepared by dilution of aliquots of the stock solution with acetonitrile to reach the concentration range 50-500 lg/mL. The prepared working solutions were analyzed under the described GC/MS conditions under Instrumentation. The peak areas were plotted against the corresponding concentrations to construct the calibration graph.
Experimental
Stock solutions of the six related substances (1000 lg/mL) were separately prepared in acetonitrile. Aliquots of these stock solutions were added to an aliquot of the parent compound stock solution and the mixture was diluted with acetonitrile. This mixture was analyzed under the described GC conditions.
Assay of tablets dosage form
A total of 10 tablets were weighed and finely powdered. Acetonitrile (30 mL) was added to an accurately weighed quantity of the powdered tablets equivalent to 50 mg DMH, stirred for 10 min then filtered into a 50-mL calibrated flask. The residue was washed with 2 · 5 mL acetonitrile and washings were added to the filtrate and diluted to final volume with acetonitrile. Aliquots of the tablet solution were diluted with acetonitrile to obtain final concentrations within the range 50-500 lg/ mL DMH and then treated as under general procedure.
Instrumentation
The GC/MS system consisted of an Agilent Technologies (Santa Clara, CA, USA) 7890A gas chromatograph and an Agilent 7683B auto injector coupled with a 5975C VL Agilent mass selective detector. The injection volume was 1 lL. The mass spectral scan rate was 2.86 scans per second. The GC was operated in splitless mode with a carrier gas (helium grade 5), flow rate was 0.7 ml/min and a column head pressure of 10 psi. The mass spectrometer was operated on the electron impact (EI) mode using an ionization voltage of 70 eV and a source temperature of 230°C. The GC injector was maintained at 300°C and the transfer line at 275°C. The temperature program used consisted of an initial temperature hold at 100°C for 1 min, ramped up to 180°C at a rate of 25°C/min and holding the temperature at 180°C for 8 min then the temperature was ramped up to 250°C at a rate of 25°C/min. The mass spectra were obtained by background subtraction and are the average of at least five scans. Results and discussion
Development of the GC/MS method
The primary goal of this study was to provide a direct, fast and reliable method for the separation and quantification of DMH in presence of its related substances and impurities. In this regard, several non-polar capillary GC columns were evaluated in an effort to find the appropriate stationary phase providing the optimum separation. The investigated stationary phases included the 5% diphenyl/95% dimethyl polysiloxane (Rtx-5 Amine), 100% dimethyl polysiloxane (Rtx-1) and trifluoropropylmethyl polysiloxane (Rtx-200 Fig. 2 . Mass spectrometry is a very useful technique for providing confirmation of chemical structure.
The electron-impact (EI) mass spectrum can be considered a molecular fingerprint for the identification of compounds. Retention times as well as masses of the molecular ions and base peak fragments of the studied compounds are listed in Table 1 .
Validation of the proposed method
The proposed method was validated according to the International Conference on Harmonization (ICH) guidelines on validation of analytical procedures [24] .
Linearity and concentration range
As mentioned earlier, DMH produces 2 well separated peaks (Fig. 2) , however, the peak corresponding to diphenhydramine is much better in shape and provides higher area values and more reliable measurement than that of 8-chlorotheophylline; therefore quantification of DMH was based on measurement of diphenhydramine peak areas. The same principle was applied in previous publications dealing with the HPLC analysis of DMH based on the diphenhydramine component only [7, 8] . The linearity of the proposed GC procedure was evaluated by analyzing a series of different concentrations of DMH (n = 8) over the concentration range 50-500 lg/mL. The following linear regression equation was generated by least squares treatment of the calibration data: A = À942752 + 22958C, (r 2 = 0.9982), where A and C are the peak area and concentration of DMH respectively. Other statistical parameters such as standard deviations of the intercept (S a ) and the slope (S b ) were calculated: 111,731 and 396 respectively. Consequently, deviation around the slope was evaluated by calculation of the RSD% of the slope (S b %) which was found 1.73%. Finally, confidence intervals of the intercept and the slope were À1216,149 to À669,356 and 21,989-23,926 respectively.
Limits of detection and quantification
The limit of detection (LOD) is defined as the concentration that has a signal-to-noise ratio of 3:1, while for limit of quantification (LOQ) the ratio considered is 10:1. The LOD and LOQ values of DMH were calculated and they were found to be 9.31 and 31.03 lg/mL respectively which can be considered sufficient for quality control analysis of DMH in its pharmaceutical formulation.
Precision and accuracy
The within-day (intra-day) precision and accuracy for the proposed method were studied at three concentration levels for DMH using three replicate determinations for each concentration within one day. Similarly, the between-day (inter-day) precision and accuracy were tested by analyzing the same three concentrations using three replicate determinations repeated on three days. Recoveries were calculated using the corresponding regression equation and they were satisfactory. The percentage relative standard deviation (RSD%) and percentage relative error (E r %) did not exceed 3% illustrating the acceptable precision and accuracy of the developed method for the estimation of DMH (Table 2) .
Specificity
Specificity is defined as the ability to access unequivocally the analyte in the presence of components that may be expected to be present, such as impurities, degradation products and (7) and DMH (8-chlorotheophylline) (8). matrix components [24] . Method specificity was already demonstrated by the successful resolution of DMH from its related substances and potential impurities (Fig. 2) .
Robustness
The robustness of an analytical procedure is a measure of its capability to remain unaffected by small but deliberate variations in method parameters and provides an indication of its reliability during normal usage [24] . Robustness was examined by evaluating the influence of small variations in the injector temperature (300 ± 5°C), starting oven temperature (100 ± 5°C) and ramp of both steps in the applied temperature program (25 ± 2°C/min). These variations did not have any significant effect on retention times of all the separated peaks or the measured response (peak area of DMH). RSD% for retention times of any of the separated peaks and DMH peak area did not exceed 5% and 3% respectively. Additionally, these minor experimental changes did not affect the resolution between any of the separated compounds.
Stability of solutions
Acetonitrile was found to be the appropriate solvent for preparing both stock and working solutions of the parent drug and its related substances in this study. Stability of working solutions in acetonitrile was tested and they were found to be stable for at least 3 days at room temperature. Retention times of the studied compounds remained unchanged and no degradation was observed during this period. Additionally, the DMH percentage recoveries were not less than 96%.
Analysis of tablets dosage forms
The developed GC/MS method was applied for the assay of DMH in its commercial pharmaceutical formulation (DramamineÒ tablets). DMH was extracted from the tablet powder using acetonitrile then dilution was done with the same solvent to reach the final concentration levels. No interfering peaks were observed from any of the excipients of the assayed tablets. A representative chromatogram obtained from the tablet extract is shown in Fig. 3 . The direct determination of DMH in its tablets without any interference from the inactive ingredients can be considered further evidence for the simplicity and selectivity of the proposed method. Results obtained were precise, accurate and in good agreement with the label claim as displayed by the adequate values of percentage recoveries, standard deviation and RSD% ( Table 3 ). The USP reference liquid chromatographic method was adopted for the estimation of DMH in its tablets [25] . Recovery data obtained from the proposed GC/MS method were statistically compared with those of the reference USP method using the Student's t-and the variance ratio F-tests. In both tests, the calculated values did not exceed the theoretical ones at the 95% confidence level which indicated that there were no significant differences between the proposed and the reference method (Table 3) . It can be concluded that the satisfactory analytical performance of the method fortifies its aptness for the routine and selective analysis of DMH in quality control units.
Conclusions
In this study, a simple, rapid and selective GC/MS procedure for determination of dimenhydrinate (DMH) in presence of six of its related substances was established. The method is considered direct using only acetonitrile as a solvent for preparation of both stock and working solutions. The samples did not require derivatization or pretreatment and the chromatograms showed excellent resolution between the parent compound and 4.00 5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 its potential impurities. Very few GC/MS methods can be found in the scientific literature for the analysis of DMH merely for toxicological and forensic purposes. To the best of our knowledge, there are no GC/MS reports for determination of the drug in its tablets dosage form. Furthermore, very few stability indicating or impurity profiling methods for DMH could be found in the literature, and they depended only on HPLC. This is the first GC method developed for the selective determination of DMH in presence of its related substances and impurities. The method can be applied in two main fields: first; separation and identification of the expected impurities of DMH; second; the quality control assay of DMH tablet dosage form. In both applications, the method showed good analytical performance and acceptable accuracy and precision. Based on the results of this study, the GC/MS method can be used for testing DMH identity, assay, and purity.
